American Oncology Network, Inc. (AONC)
2024-06-30 | ||||
---|---|---|---|---|
Total revenue | 433,982 | |||
General and administrative expenses | 36,738 | |||
Cost of revenue | 404,589 | |||
Transaction expenses | 664 | |||
Total costs and expenses | 441,991 | |||
Loss from operations | -8,009 | |||
Interest income | 1,025 | |||
Interest expense | 1,833 | |||
Other (expense) income, net | 5,547 | |||
Loss before income taxes, equity loss in affiliate, and noncontrolling interest | -3,270 | |||
Income tax expense (benefit) | -324 | |||
Loss before equity loss in affiliate and noncontrolling interest | -2,946 | |||
Equity in loss of affiliate | -179 | |||
Net loss before noncontrolling interest | -3,125 | |||
Net loss attributable to redeemable noncontrolling interest | -6,412 | |||
Net loss attributable to noncontrolling interest | -334 | |||
Net loss attributable to class a common stockholders, basic | 3,621 | |||
Net loss attributable to class a common stockholders, diluted | 3,621 | |||
Basic eps | 120 | |||
Diluted eps | -110 | |||
Basic average shares | 11,377,407 | |||
Diluted average shares | 37,089,605 |